Coya Therapeutics Inc [NASDAQ: COYA] price surged by 5.28 percent to reach at $0.32.
A sum of 146144 shares traded at recent session while its average daily volume was at 177.38K shares. Coya Therapeutics Inc shares reached a high of $6.3919 and dropped to a low of $6.07 until finishing in the latest session at $6.38.
The one-year COYA stock forecast points to a potential upside of 60.3. The average equity rating for COYA stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Coya Therapeutics Inc [COYA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for COYA shares is $16.07 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on COYA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Lake Street have made an estimate for Coya Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 09, 2025. While these analysts kept the previous recommendation, D. Boral Capital raised their target price to Buy. The new note on the price target was released on December 04, 2024, representing the official price target for Coya Therapeutics Inc stock.
The Price to Book ratio for the last quarter was 3.91, with the Price to Cash per share for the same quarter was set at 1.34.
COYA Stock Performance Analysis:
Coya Therapeutics Inc [COYA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.19. With this latest performance, COYA shares dropped by -4.20% in over the last four-week period, additionally plugging by 19.65% over the last 6 months – not to mention a rise of 11.34% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for COYA stock in for the last two-week period is set at 56.47, with the RSI for the last a single of trading hit 0.36, and the three-weeks RSI is set at 0.40 for Coya Therapeutics Inc [COYA]. The present Moving Average for the last 50 days of trading for this stock 6.09, while it was recorded at 6.09 for the last single week of trading, and 6.10 for the last 200 days.
Insight into Coya Therapeutics Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Coya Therapeutics Inc [COYA] shares currently have an operating margin of -503.76% and a Gross Margin at 99.31%. Coya Therapeutics Inc’s Net Margin is presently recorded at -462.25%.
Coya Therapeutics Inc (COYA) Capital Structure & Debt Analysis
According to recent financial data for Coya Therapeutics Inc. ( COYA), the Return on Equity (ROE) stands at -62.18%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -54.54%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Coya Therapeutics Inc’s Return on Invested Capital (ROIC) is -67.56%, showcasing its effectiveness in deploying capital for earnings.
Coya Therapeutics Inc (COYA) Efficiency & Liquidity Metrics
Based on Coya Therapeutics Inc’s (COYA) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Coya Therapeutics Inc (COYA) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Coya Therapeutics Inc. (COYA) effectively leverages its workforce, generating an average of -$2303750.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 8.73% and a Quick Ratio of 8.73%, indicating strong ability to cover short-term liabilities.
COYA Stock EPS
With the latest financial reports released by the company, Coya Therapeutics Inc posted -0.18/share EPS, while the average EPS was predicted by analysts to be reported at -0.14/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for COYA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Coya Therapeutics Inc go to -9.22%.
Coya Therapeutics Inc [COYA] Institutonal Ownership Details
There are presently around $22.70%, or 24.07%% of COYA stock, in the hands of institutional investors. The top three institutional holders of COYA stocks are: DME CAPITAL MANAGEMENT, LP with ownership of 1.27 million shares, which is approximately 8.5418%. VANGUARD GROUP INC, holding 0.85 million shares of the stock with an approximate value of $$5.12 million in COYA stocks shares; and VANGUARD GROUP INC, currently with $$3.94 million in COYA stock with ownership which is approximately 4.3541%.
